Work

Histone Acetylation Modifiers in the Pathogenesis of Alzheimer’s Disease

Year: 2015
Type: review
Abstract: It is becoming more evident that histone acetylation, as one of the epigenetic modifications or markers, plays a key role in the etiology of Alzheimer's disease (AD). Histone acetylases and histone deacetylases (HDACs) are the well-known covalent enzymes that modify the reversible acetylation of lysine residues in histone amino-terminal domains. In AD, however, the roles of these enzymes are controversial. Some recent studies indicate that HDAC inhibitors are neuroprotective by regulating memory and synaptic dysfunctions in cellular and animal models of AD; while on the other hand, increase of histone acetylation have been implicated in AD pathology. In this review, we focus on the recent advances on the roles of histone acetylation covalent enzymes in AD and discuss how targeting these enzymes can ultimately lead to therapeutic approaches for treating AD.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W1495719268
FWCI: 1.111
Cites: 84
Cited by: 142
Related to: 9